48th Annual Meeting of the European Association for the Study of the Liver. Amsterdam, The Netherlands. April 2013 [Abstract 101]. 61 Schinazi RF, Bassit L, Clayton MM et al. Evaluation of single and combination therapies with tenofovir disoproxil fumarate and emtricitabine in vitro and in a robust mouse model supporting high levels of hepatitis B virus replication. Decitabine price Antimicrob Agents Chemother 2012; 56: 6186–6191. 62 Avihingsanon
A, Lewin SR, Kerr S et al. Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naïve HIV-HBV coinfection in Thailand. Antivir Ther 2010; 15: 917–922. 63 Liaw YF, Sheen IS, Lee CM et al. Tenofovir disoproxil fumarate (TDF), emtricitabine/TDF, Selleck MLN0128 and entecavir in patients with decompensated chronic hepatitis B liver disease. Hepatology 2011; 53: 62–72. 64 Dore GJ, Cooper DA, Pozniak AL et al. Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus. J Infect Dis 2004; 189: 1185–1192. 65 Polsen J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179–1197. 66 Kumar M, Satapathy S, Monga R et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology 2007; 45: 97–101. 67 Yu JW, Sun LJ, Zhao YH, Kang P, Lil SC. The study of efficacy of lamivudine
in patients with severe acute hepatitis B. Dig Dis Sci 2010; 55: 775–783. 68 Yu JW, Sun LJ, Yan BZ, Kang P, Zhao YH. Lamivudine treatment is associated with improved survival in fulminant hepatitis B. Liver Int 2011; 31: 499–506. 69 Miyake Y, Iwasaki Y, Takaki A et al. Lamivudine treatment improves the prognosis of fulminant hepatitis B. Intern Med 2008; 47: 1293–1299. 70 Akhan S, Sayan M. HIV and acute HBV infection: First case report from Kocaeli, Turkey. Hepatol Int 2012; 6: 134. 71 Ikeda-Kamimura M,
Horiba M. Seroconversion of acute hepatitis B by antiretroviral therapy in an HIV-1 infected patient. only Acta Gastroenterol Belg 2010; 73: 389–391. 72 Sagredo S, Mancilla C, Estuardo N, Poniachik J. Fulminant hepatic failure by hepatitis B virus in a patient with human immunodeficiency virus infection. Report of one case. [In Spanish]. Rev Med Chil 2011; 139: 1336–1339. 73 Schirmer P, Winters M, Holodniy M. HIV-HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir/emtricitabine without antiviral resistance. J Clin Virol 2011; 52: 261–264. 74 Jochum C, Gieseler RK, Gawlista et al. Hepatitis B-associated acute liver failure: immediate treatment with entecavir inhibits hepatitis B virus replication and potentially its sequelae. Digestion 2009; 80:235–240. 75 De Socio GV, Mercuri A, Di Candilo F, Baldelli F. Entecavir to treat severe acute hepatitis B.